Advanced Biomed (ADVB) Other Non-Current Assets (2025 - 2026)

Advanced Biomed (ADVB) posted Other Non-Current Assets of $2184.0 for Q1 2026, up 128.45% sequentially from $956.0 in Q4 2025.

Advanced Biomed (ADVB) Other Non-Current Assets (2025 - 2026) Analysis & Trends

Advanced Biomed has reported Other Non-Current Assets for 2 years, with the latest figure at $2184.0 in Q1 2026.

Quarterly Other Non-Current Assets changed N/A year-over-year to $2184.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2184.0 (changed N/A YoY) and the FY2025 annual result came in at $2605.0, changed N/A from the prior year.
Other Non-Current Assets advanced to $2184.0 in Q1 2026 per ADVB's latest filing, from $956.0 in the prior quarter.
Over five years, Other Non-Current Assets peaked at $74770.0 in Q3 2025 and troughed at $956.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Other Non-Current Assets (Qtr)
1	Thermo Fisher Scientific	213.88 Bn	209.81 Bn	8.34 Bn	5.62 Bn
2	Danaher	140.65 Bn	136.30 Bn	3.61 Bn	4.39 Bn
3	Idexx Laboratories	46.02 Bn	45.83 Bn	779.09 Mn	567.73 Mn
4	Agilent Technologies	39.85 Bn	38.05 Bn	990.00 Mn	1.18 Bn
5	Iqvia Holdings	39.20 Bn	37.12 Bn	1.44 Bn	558.00 Mn
6	Natera	38.80 Bn	37.70 Bn	696.04 Mn	51.00 Mn
7	Illumina	30.11 Bn	28.94 Bn	770.00 Mn	576.00 Mn
8	Mettler Toledo International	28.66 Bn	28.61 Bn	650.22 Mn	448.88 Mn
9	Quest Diagnostics	26.24 Bn	25.61 Bn	1.03 Bn	277.00 Mn
10	Advanced Biomed	10.46 Mn	10.46 Mn	-	2,184.00

Download Data